Published abstracts

Effect of Tirzepatide on Office Blood Pressure Levels in Overweight or Obese Individuals Without Type 2 Diabetes: A Systematic Review and Meta-Analysis

ESH 2024

D. Patoulias, K. Imprialos, K. Stavropoulos, T. Koufakis, P. Karakasis, A. Varouktsi, I. Zografou, A. Katsimardou, K. Petidis, M. Doumas — Journal of Hypertension 42(Suppl), ESH 2024 · Participation catalogue 2007–2026 (ed. 13/9/2026)

Effect of Semaglutide Versus Other GLP-1 Receptor Agonists on Office Blood Pressure Levels Among Subjects with Type 2 Diabetes: A Meta-Analysis

ESH 2024

Journal of Hypertension 42(Suppl 1):e146 · DOI 10.1097/01.hjh.0001020820.64485.c0

Effect of GLP-1 Receptor Agonists on Office Blood Pressure Levels Among Overweight or Obese Subjects Treated with Antipsychotic Drugs: A Meta-Analysis

ESH 2024

Journal of Hypertension 42(Suppl 1):e230 · DOI 10.1097/01.hjh.0001021828.69534.09

#6754 · The Effect of Reduced Renal Function on Sexual Dysfunction in Patients with Heart Failure

ERA 2023

Nephrology Dialysis Transplantation, ERA Congress abstract · DOI 10.1093/ndt/gfad063d_6754

Safety and Efficacy of SARS-CoV-2-Specific T Cells as Adoptive Immunotherapy for High-Risk COVID-19 Patients: A Phase I/II, Randomized Clinical Trial

ISCT 2022 Annual Meeting

A. Papadopoulou, G. Karavalakis, E. Papadopoulou, A. Xochelli, Z. Bousiou, A. Vogiatzoglou, P.G. Papayanni, A. Georgakopoulou et al. (K. Imprialos in the author group) — proceedings/DOI metadata · Participation catalogue 2007–2026 (ed. 13/9/2026)

Major Adverse Events with the Use of Finerenone in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

ESH 2022

D. Patoulias, A. Katsimardou, A. Sviggou, V. Kordalis, A. Aidinis, K. Imprialos, K. Stavropoulos et al. · Participation catalogue 2007–2026 (ed. 13/9/2026)

Exercise Capacity and Mortality Risk in a Wide Age Spectrum Cohort of 750,302 Veterans

ESH 2022

Journal of Hypertension 40(Suppl 1):e50 · DOI 10.1097/01.hjh.0000835684.89768.11

Meta-Analysis of Dedicated Heart Failure Trials Evaluating the Effect of Sacubitril/Valsartan on Major Cardiac Rhythm Disorders

ESH 2022

Journal of Hypertension 40(Suppl 1):e69 · DOI 10.1097/01.hjh.0000835856.48834.53

Meta-Analysis Evaluating the Efficacy of SGLT-2 Inhibitors in Subjects with Heart Failure with Preserved Left Ventricular Ejection Fraction

ESH 2022

Journal of Hypertension 40(Suppl 1):e69–e70 · DOI 10.1097/01.hjh.0000835860.07190.e8

Renal Effects of SGLT-2 Inhibitors in Patients with Heart Failure with Reduced or Preserved Ejection Fraction

ESH 2022

Journal of Hypertension 40(Suppl 1):e70 · DOI 10.1097/01.hjh.0000835864.84322.25

Cardiovascular Efficacy of SGLT-2 Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Patients with Heart Failure According to Mineralocorticoid Receptor Antagonist Use

ESH 2022

Journal of Hypertension 40(Suppl 1):e70 · DOI 10.1097/01.hjh.0000835868.58687.e7

GLP-1 Receptor Agonists Do Not Decrease the Risk for Coronary Revascularization in Patients with Type 2 Diabetes

ESH 2022

Journal of Hypertension 40(Suppl 1):e164 · DOI 10.1097/01.hjh.0000837028.88430.4f

COVID-19 Is Associated with Endothelial Dysfunction: A Meta-Analysis of Observational Studies

ESH 2022

Journal of Hypertension 40(Suppl 1):e169 · DOI 10.1097/01.hjh.0000837084.91831.2a

Coronavirus Disease-2019 Is Associated with Arterial Stiffness Impairment: A Meta-Analysis of Observational Studies

ESH 2022

Journal of Hypertension 40(Suppl 1):e169 · DOI 10.1097/01.hjh.0000837088.20576.eb

Colchicine for the Prevention of COVID-19 “Hard” Outcomes: All That Glitters Is Not Gold. An Updated Analysis of Randomized Controlled Trials

ESH 2022

Journal of Hypertension 40(Suppl 1):e169 · DOI 10.1097/01.hjh.0000837092.75679.15

Cardiovascular Efficacy of GLP-1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

ESH 2022

Journal of Hypertension 40(Suppl 1):e187 · DOI 10.1097/01.hjh.0000837316.89812.46

“Which One Should I Choose, a GLP-1RA or a SGLT2 Inhibitor? Or Maybe Both?” A Pooled Analysis of Cardiovascular Outcome Trials

ESH 2022

Journal of Hypertension 40(Suppl 1):e187–e188 · DOI 10.1097/01.hjh.0000837324.54362.4b

Meta-Analysis Addressing the Effect of SGLT-2 Inhibitors on Flow-Mediated Dilation in Patients with Type 2 Diabetes Mellitus

ESH 2022

Journal of Hypertension 40(Suppl 1):e188 · DOI 10.1097/01.hjh.0000837328.80820.fb

Beneficial Effect of SGLT-2 Inhibitors on Right Ventricular Systolic Function in Patients with Type 2 Diabetes Mellitus: A Pilot, Observational Study

ESH 2022

Journal of Hypertension 40(Suppl 1):e188 · DOI 10.1097/01.hjh.0000837332.70071.3f

Cardiovascular Outcomes with Finerenone According to Status of Glycemia at Baseline and Prior Treatment with Newer Antidiabetics Among Patients with Type 2 Diabetes Mellitus

ESH 2022

Journal of Hypertension 40(Suppl 1):e188 · DOI 10.1097/01.hjh.0000837336.21736.d6

Effect of SGLT-2 Inhibitors on Arterial Stiffness Under Static or Ambulatory Conditions: A Meta-Analysis of Randomized Controlled Trials

ESH 2022

Journal of Hypertension 40(Suppl 1):e188–e189 · DOI 10.1097/01.hjh.0000837340.53743.9e

Meta-Analysis of the Effect of Dual GIP and GLP-1 Receptor Agonists on Blood Pressure Levels in Patients with Type 2 Diabetes Mellitus

ESH 2022

Journal of Hypertension 40(Suppl 1):e300–e301 · DOI 10.1097/01.hjh.0000838652.68523.bc

Blood Pressure Response to an Isometric Contraction and 3 Minute of Treadmill Test Predicts Left Ventricular Hypertrophy in Normotensives

ESH–ISH Joint Meeting 2021

A. Pittaras, C. Faselis, H. Grassos, L. Poulimenos, M. Doumas, K. Stavropoulos, K. Kyfnidis, I. Samuel et al. (K. Imprialos in the author group) · Participation catalogue 2007–2026 (ed. 13/9/2026)

P10 · Effect of Long-Term Administration of SGLT-2 Inhibitors on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus: A Prospective, Observational Study

CVOT Summit 2021 — Cardiovascular Outcome Trial Summit

D. Patoulias, C. Papadopoulos, A. Katsimardou, K. Imprialos, K. Stavropoulos, I. Zografou, M. Toumpourleka, A. Tranidou, S. Bakatselos, A. Karagiannis, M. Doumas — published abstract collection · Participation catalogue 2007–2026 (ed. 13/9/2026)

Impact of Sham Procedure on Blood Pressure Levels in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of Renal Denervation Trials

ESH 2021

Journal of Hypertension 39(Suppl 1):e10 · DOI 10.1097/01.hjh.0000744460.17589.68

Renin-Angiotensin System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Evidence for Significant Geographical Disparities

ESH 2021

Journal of Hypertension 39(Suppl 1):e37–e38 · DOI 10.1097/01.hjh.0000744752.74893.6c

Differences in Biomarkers Among Heart Failure Patients with or without Hypertension

ESH 2021

Journal of Hypertension 39(Suppl 1):e98 · DOI 10.1097/01.hjh.0000745384.13789.f4

Left Ventricular Mass and Sexual Function in Hypertensive Patients with Heart Failure: So Far So Good?

ESH 2021

Journal of Hypertension 39(Suppl 1):e98 · DOI 10.1097/01.hjh.0000745388.07692.44

Obesity Paradox and Hypertension: New Insights in Heart Failure Patients

ESH 2021

Journal of Hypertension 39(Suppl 1):e98–e99 · DOI 10.1097/01.hjh.0000745392.33593.c7

Meta-Analysis Evaluating the Risk of Atrial Fibrillation with Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials

ESH 2021

Journal of Hypertension 39(Suppl 1):e101 · DOI 10.1097/01.hjh.0000745428.72000.19

Surrogate Cardiovascular Outcomes with Sodium-Glucose Co-Transporter-2 Inhibitors in Women: An Updated Meta-Analysis

ESH 2021

Journal of Hypertension 39(Suppl 1):e101–e102 · DOI 10.1097/01.hjh.0000745432.16180.01

A Meta-Analysis Assessing the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Surrogate Endpoints in Patients with Heart Failure with Reduced Ejection Fraction

ESH 2021

Journal of Hypertension 39(Suppl 1):e102 · DOI 10.1097/01.hjh.0000745436.48395.ae

Cardiovascular Outcomes with Sodium-Glucose Co-Transporter-2 Inhibitors in Asians: An Updated Meta-Analysis

ESH 2021

Journal of Hypertension 39(Suppl 1):e176–e177 · DOI 10.1097/01.hjh.0000746380.15169.8c

Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance Imaging

ESH 2021

Journal of Hypertension 39(Suppl 1):e177 · DOI 10.1097/01.hjh.0000746384.99861.d2

Effect of a GLP-1 Receptor Agonist and SGLT-2 Inhibitor Combination on Blood Pressure Levels Compared to SGLT-2 Inhibitor Alone

ESH 2021

Journal of Hypertension 39(Suppl 1):e212 · DOI 10.1097/01.hjh.0000746848.72715.67

Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Black Patients

ESH 2021

Journal of Hypertension 39(Suppl 1):e215–e216 · DOI 10.1097/01.hjh.0000746888.24529.47

Hypertensive Patients as Candidates for Renal Sympathetic Denervation: Consensus Opinion of Hypertension Experts in Greece

ESH 2021

Journal of Hypertension 39(Suppl 1):e289 · DOI 10.1097/01.hjh.0000747780.07675.d3

Views and Perspectives of Hypertension Experts in Greece Regarding the Efficacy and Safety of Renal Sympathetic Denervation

ESH 2021

Journal of Hypertension 39(Suppl 1):e290 · DOI 10.1097/01.hjh.0000747784.98987.c8

Effect of Renal Denervation on Ambulatory Blood Pressure in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of Randomized, Sham-Controlled Trials

ESH 2021

Journal of Hypertension 39(Suppl 1):e290 · DOI 10.1097/01.hjh.0000747788.40711.72

Effect of Renal Denervation on Office Blood Pressure in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of Randomized, Sham-Controlled Trials

ESH 2021

Journal of Hypertension 39(Suppl 1):e290 · DOI 10.1097/01.hjh.0000747792.19236.1f

Effect of Renal Denervation on Renal Function of Patients with Uncontrolled Hypertension: Insights from a Systematic Review and Meta-Analysis of Randomized, Sham-Controlled Trials

ESH 2021

Journal of Hypertension 39(Suppl 1):e290–e291 · DOI 10.1097/01.hjh.0000747796.33067.91

Meta-Analysis of Dedicated Renal Outcome Trials Assessing the Cardio-Renal Efficacy of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease and Albuminuria

ESH 2021

Journal of Hypertension 39(Suppl 1):e306 · DOI 10.1097/01.hjh.0000748012.89266.10

SGLT-2 Inhibitors Are Protective Against Acute Kidney Injury Across the Cardiovascular and Renal Outcome Trials: An Updated Meta-Analysis

ESH 2021

Journal of Hypertension 39(Suppl 1):e306–e307 · DOI 10.1097/01.hjh.0000748016.18928.9f

Hypertension and Heart Failure with Mid-Range Ejection Fraction: A Comparative Approach in Heart Failure Subgroups

ESH 2019

Journal of Hypertension 37:e114 · DOI 10.1097/01.hjh.0000571480.58747.1d

Hypertension and Erectile Dysfunction: New Insights in Heart Failure Patients

ESH 2019

Journal of Hypertension 37:e118 · DOI 10.1097/01.hjh.0000571536.94186.73

Hypertension and Right Ventricular Systolic Function: An Echocardiographic Cross Sectional Study in Heart Failure Patients

ESH 2019

Journal of Hypertension 37:e118 · DOI 10.1097/01.hjh.0000571540.71316.6a

Hypertension and Antihypertensive Therapy in HF Patients According to Gender

ESH 2019

Journal of Hypertension 37:e170 · DOI 10.1097/01.hjh.0000572176.71728.a8

Atrial Fibrillation Is Associated to Sexual Function of Hypertensive Patients with Heart Failure: New Findings, New Considerations?

ESH 2019

Journal of Hypertension 37:e185 · DOI 10.1097/01.hjh.0000572380.39899.0f

The Relation of Hypertension with Female Sexual Dysfunction: The Heart Failure Paradigm

ESH 2019

Journal of Hypertension 37:e240 · DOI 10.1097/01.hjh.0000573072.90280.a7

Blood Pressure Levels and Hospitalizations in Heart Failure Patients: Is Lower the Better?

ESH 2019

Journal of Hypertension 37:e244 · DOI 10.1097/01.hjh.0000573112.51269.50

Hypertensive Patients with Heart Failure

ESH 2019

Journal of Hypertension 37:e246 · DOI 10.1097/01.hjh.0000573148.68302.db

Is There an Association Between Hypertension and Right Ventricular Diastolic Function in Heart Failure Patients?

ESH 2019

Journal of Hypertension 37:e309 · DOI 10.1097/01.hjh.0000573876.32764.82

5th Cardiovascular Outcome Trial (CVOT) Summit — Μόναχο

P26 · Glucagon-Like Peptide-1 Receptor Agonist on Top of Sodium-Glucose Cotransporter-2 Inhibitor Treatment Compared to Sodium-Glucose Cotransporter-2 Inhibitor Alone: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Blood Pressure Response to an Isometric Contraction Predicts Left Ventricular Hypertrophy

AHA Scientific Sessions 2019 — Circulation

A. Pittaras, P.F. Kokkinos, M. Doumas, I. Samuel, H. Grassos, M. Kallistratos, L. Poulimenos, G. Pyriovoli, D. Gourlis, A. Manolis, K. Imprialos, K. Stavropoulos, C. Faselis · Circulation 140(Suppl 1):A13806 · DOI 10.1161/circ.140.suppl_1.13806

Female Sexual Dysfunction with Diuretics in Women with Arterial Hypertension

ESH 2018

Journal of Hypertension 36(Suppl 1):e196 · DOI 10.1097/01.hjh.0000539543.01157.f5

The Impact of Diuretics on Erectile Function in Patients with Arterial Hypertension

ESH 2018

First author: K. Imprialos; K. Stavropoulos, S. Bouloukou, D. Patoulias, A. Sachinidis, K. Dimitriadis, K. Tsioufis, A. Pittaras, A.J. Manolis, A. Karagiannis · Journal of Hypertension 36(Suppl 1):e196 · DOI 10.1097/01.hjh.0000539544.08781.b8

PS22/12 · A Pregnant Woman with Pseudohyperaldosteronism Due to Mumijo Consumption: A Licorice-Like Syndrome

ESH 2018

K. Imprialos (first author), K. Stavropoulos, D. Patoulias, S. Bouloukou, G. Kerpiniotis, G. Lales, A. Manafis, C. Mitas, K. Petidis, V. Athyros, A. Karagiannis, M. Doumas · Journal of Hypertension 36(Suppl 1):e250 · DOI 10.1097/01.hjh.0000539711.78560.e3 · Participation catalogue 2007–2026 (ed. 14/9/2026, 273 entries)

Do We Have to Screen Patients with Adrenal Incidentaloma for Primary Aldosteronism?

ESH 2018

Presented in “Oral Presentations in Poster Area — Mechanisms of Hypertension” (final programme, p. 237) · Journal of Hypertension 36(Suppl 1):e303 · DOI 10.1097/01.hjh.0000539885.36949.6d · Participation catalogue 2007–2026 (ed. 14/9/2026, 273 entries)

SP489 · Excess Right Atrial Congestion and Pulmonary Circulation Loading Over the Long Interdialytic in Patients Receiving Thrice-Weekly Hemodialysis

ERA-EDTA 2016

Nephrology Dialysis Transplantation 31(Suppl 1):i256 · DOI 10.1093/ndt/gfw172.29

MP540 · Changes in Left Ventricular Sizing and Function Over the 3-Day and 2-Day Interdialytic Intervals in Hemodialysis Patients

ERA-EDTA 2016

Nephrology Dialysis Transplantation 31(Suppl 1):i520 · DOI 10.1093/ndt/gfw196.19

PP.10.15 · Prevalence of Sexual Dysfunction in Females with Resistant Hypertension

ESH 2016

Journal of Hypertension 34(Suppl 2):e174 · DOI 10.1097/01.hjh.0000491819.57465.35

PP.10.23 · Evaluation of Sodium Intake in Patients with Resistant Hypertension: Clinical Practice in Greece

ESH 2016

Journal of Hypertension 34(Suppl 2):e175 · DOI 10.1097/01.hjh.0000491826.53117.8f

PP.23.12 · Out-of-Office Blood Pressure Measurement in Patients with Resistant Hypertension in Everyday Clinical Practice: Still a Long Journey to Go

ESH 2016

Journal of Hypertension 34(Suppl 2):e257 · DOI 10.1097/01.hjh.0000492083.56615.7b

PP.23.20 · Prevalence and Severity of Erectile Dysfunction in Patients with Resistant Hypertension

ESH 2016

Journal of Hypertension 34(Suppl 2):e259 · DOI 10.1097/01.hjh.0000492091.81271.cf

PP.09.05 · Hemodialysis Improves Right Ventricular Sizing and Reduces Pulmonary Circulation Loading in Patients with End-Stage Renal Disease

ESH 2016

P. Georgianos, V. Kamperidis, H. Loutradis, K. Tsilonis, K. Imprialos, A. Boutou, L. Alexakis, M. Galani-Manolakou, H. Karvounis, P. Sarafidis — poster with no assigned DOI · Participation catalogue 2007–2026 (12/9/2026)

Poor Adoption of Guideline Recommendations About Out-of-Office Blood Pressure Measurement in Patients with Resistant Hypertension

American Society of Hypertension (ASH) 2016 — conference abstract volume

M. Doumas, P. Kokkinos, C. Faselis, A. Pittaras, I. Zografou, P. Deligkaris, C. Boutari, K. Imprialos, K. Stavropoulos et al. · Participation catalogue 2007–2026 (ed. 13/9/2026)

Poster 14 · Effect of Hemodialysis on Novel Echocardiographic and Tissue Doppler-Derived Indices of Left Ventricular Function in End-Stage Renal Disease Patients

ESH 2016

P. Georgianos, V. Kamperidis, H. Loutradis, K. Tsilonis, K. Imprialos, G. Ioannidis, E. Barberi, H. Karvounis, P. Sarafidis — poster with no assigned DOI · Participation catalogue 2007–2026 (12/9/2026)

SP535 · Effect of Hemodialysis on Systolic and Diastolic Performance of Right Ventricle in Patients with End-Stage Renal Disease

ERA-EDTA 2015 (52nd Congress)

K. Tsilonis, P. Sarafidis, V. Kamberidis, P. Georgianos, K. Imprialos (spelled “Imbrialos” in the source), E. Tzatzaki, L. Alexakis, M. Galani-Manolakou et al. — NDT 30(Suppl 3) · Participation catalogue 2007–2026 (ed. 13/9/2026)

SP573 · Echocardiographic Evaluation of Acute Changes in Novel Indices of Left Ventricular Systolic and Diastolic Function During Hemodialysis in End-Stage Renal Disease Patients

ERA-EDTA 2015 (52nd Congress)

K. Tsilonis, P. Sarafidis, V. Kamberidis, P. Georgianos, K. Imprialos (spelled “Imbrialos” in the source), E. Tzatzaki, G. Ioannidis, E. Barberi et al. — NDT 30(Suppl 3) · Participation catalogue 2007–2026 (ed. 13/9/2026)

PP.17.12 · Comparison of Two Validated Devices for Ambulatory Blood Pressure Monitoring Under Static Conditions

ESH 2015

A. Lazaridis, P. Sarafidis, K. Imprialos, P. Georgianos, K. Avranas, M. Doumas, A. Protogerou, V. Athyros, A. Karagiannis · Journal of Hypertension 33(Suppl 1):e285 · DOI 10.1097/01.hjh.0000468235.01788.40 · Participation catalogue 2007–2026 (ed. 14/9/2026, 273 entries)

PP.17.13 · Comparison of Mobil-O-Graph and Spacelabs 90217 Ambulatory Monitoring Devices in Healthy Volunteers

ESH 2015

K. Imprialos (first author), P. Sarafidis, A. Lazaridis, P. Georgianos, K. Avranas, M. Doumas, A. Protogerou, E. Nasothimiou, V. Athyros, A. Karagiannis · Journal of Hypertension 33(Suppl 1):e285 · DOI 10.1097/01.hjh.0000468236.09411.ee · Participation catalogue 2007–2026 (ed. 14/9/2026, 273 entries)

P9.13 · A Study on Ambulatory Measurement of Central Hemodynamics on Healthy Individuals with No Cardiovascular Risk Factors

ARTERY 2014 — Artery Research (conference abstract volume)

A. Lazaridis, E. Papadopoulou, A. Varouktsi, K. Imprialos, M. Doumas, E. Gkaliagkousi, V. Athiros, A. Karagiannis · Participation catalogue 2007–2026 (ed. 13/9/2026)

8099-31 · Nanotechnology in Cancer Treatment

SPIE Optics + Photonics — Biosensing and Nanomedicine IV (proceedings)

M. Mironidou-Tzouveleki, K. Imprialos, A. Kintsakis — published proceedings (Proc. SPIE 809917, DOI metadata) · Participation catalogue 2007–2026 (ed. 13/9/2026)

CORA 2011 — Controversies in Rheumatology and Autoimmunity, Φλωρεντία

215 · Targeting Vascular Endothelial Growth Factor (VEGF) in Rheumatoid Arthritis (RA)

3rd EMUNI Research Souk — Innovation and Employability: The Universities Challenge (πολυκεντρική διοργάνωση με συμμετοχή ΑΠΘ)

Targeting Vascular Endothelial Growth Factor (VEGF) in Rheumatoid Arthritis (RA)

2114·P13 · Bisphosphonate-Related Osteonecrosis of the Jaw (BONJ)

WorldPharma 2010 — 16th World Congress of Basic and Clinical Pharmacology

G. Dimosiari, K. Imprialos, M. Mironidou-Tzouveleki — poster · Participation catalogue 2007–2026 (ed. 13/9/2026)

Medical Facts on Alcohol Consumption and Abuse

EMUNI Research Souk 2010 — proceedings

K. Imprialos — paper in the proceedings, pp. 1004–1042; full author list not recovered.